1 Stock That Could Double Easily in 2021

This one stock that could double in 2021 belongs to a booming industry that simply won’t go away, even after the pandemic is over.

| More on:
Arrowings ascending on a chalkboard

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

There are a lot of opportunities out there for investors on the TSX today. However, if you’re looking for a stock that could double this year alone, there’s one word you need to consider: value.

Value encompasses it all. Value stocks are those that are cheap relative to past performance and future outlook. Valuations are strong, but the stock remains undervalued. With that in mind, while there are a few stocks in value territory, there aren’t as many that could double this year.

But there is one stock that could double easily in 2021, and it’s where I’m going to focus today.

Growing industry post-pandemic

If you want a stock that could double this year, then you’ll need to look for industries that are set to see strong growth after the pandemic is over. One such industry is the healthcare industry — specifically, telehealth. Virtual healthcare was already on the rise before the pandemic, but it soon became a necessity. On the TSX today, there are multiple telehealth companies doing exceedingly well.

But if there is one stock that could double in 2021, it has to be WELL Health Technologies (TSX:WELL). WELL health stock continues to expand by leaps and bounds, taking on a growth-through-acquisition strategy that is the envy of competitors. This growth has sent revenue soaring, most recently up 150% year over year. Meanwhile, its software and services revenue is up a whopping 345%!

But could all this end when the pandemic is over? In short: no. Telehealth has proven to be a cost-saving method that keeps patients and doctors safe and provides healthcare more often and faster than traditional methods. So, unless you really need something looked at in person, virtual seems to be the way the world is headed. Considering the shortage in medical care many Canadians face, especially in rural communities, this is a necessity that has been sorely needed for years.

A stock that could double, thanks to a pullback

So, why am I so certain shares in WELL health stock are going to double this year? That’s because of the recent pullback. Shares in the company soared during the pandemic, but with a vaccine underway, tech stocks, including virtual healthcare, experienced a pullback on the TSX today.

In the case of WELL health stock, shares grew 657% from the market crash to peak prices earlier this year. Since then, shares have come down by 26% in the pullback. That provides investors with a strong opportunity to jump in on this stock before growth happens yet again.

A correction will come on the TSX today in terms of tech stocks. Many will see massive growth, as consumers become eager to spend, and revenue continues to pour in. WELL health stock will be one of those stocks. Given the share price of $6.90 as of writing and 52-week highs were at $9.84, this alone could be a fast turnaround in the share price for investors on the TSX today.

Bottom line

The best part? WELL health stock is cheap. The company’s valuation trades at 5.2 times book value, despite spending so much on acquisitions. Analysts estimate the stock could definitely jump to as high as $13.90 per share in the next year. That right there would make it a stock that could double easily in 2021. But for this company, I would hold onto WELL health stock for years to come. A long-term hold in the virtual healthcare industry is one you’re unlikely to regret down the line.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of WELL Health Technologies.

More on Investing

growing plant shoots on stacked coins
Dividend Stocks

2 Oversold TSX Dividend Stocks to Buy Now and Own for 25 Years

These top TSX dividend stocks look oversold and now offer attractive yields for TFSA and RRSP investors.

Read more »

money cash dividends
Investing

Passive-Income Power: How to Make $105/Week TAX FREE in a Bear Market

Investors may want to pursue a passive-income strategy in this bear market by snagging dividend stocks like Freehold Royalties Ltd.…

Read more »

Money growing in soil , Business success concept.
Energy Stocks

3 Growth Stocks up +30% in 2022

These three growth stocks are up over 30% in 2022 alone but have come down in the last few weeks…

Read more »

Oil pumps against sunset
Energy Stocks

2 Energy Stocks That Jumped Over 60% This Year

Consider investing in these two energy stocks amid the recent pullback after putting up stellar gains earlier this year.

Read more »

Profit dial turned up to maximum
Dividend Stocks

RRSP Investors: 2 Undervalued TSX Stocks to Buy Now for Total Returns

Top TSX dividend stocks are now on sale for RRSP investors seeking attractive total returns.

Read more »

TFSA and coins
Dividend Stocks

2 Beaten-Down Stocks to Buy for Your TFSA

Two beaten-down, but high-yield TSX stocks are profitable options for TFSA investors.

Read more »

Volatile market, stock volatility
Stocks for Beginners

3 Top TSX Stocks to Buy in Volatile Markets

Sitting on cash? Consider these three TSX stocks for the long term.

Read more »

Hand writing Time for Action concept with red marker on transparent wipe board.
Dividend Stocks

Inflation Soars to 7.7%: 1 Dividend Stock to Buy Now

Enbridge (TSX:ENB)(NYSE:ENB) stock looks like a magnificent dividend stock to help Canadians deal with inflation at 7.7%.

Read more »